Floatz logo

Therapeutic Asset Ratings

567 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4)
Urinary Bladder Cancer
Fred Hutchinson Cancer CenterP2BB (66)
FILGRASTIM
Mantle Cell Lymphoma
Fred Hutchinson Cancer CenterP2BB (66)
METHOTREXATE
Congenital Amegakaryocytic Thrombocytopenia
Fred Hutchinson Cancer CenterP2BB (66)
METHOTREXATE
Diamond-Blackfan Anemia
Fred Hutchinson Cancer CenterP2BB (66)
Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs
Myelodysplastic Syndrome
Fred Hutchinson Cancer CenterP2/3BB (66)
Cytosin-Arabinosid
Chronic Myelomonocytic Leukemia
Fred Hutchinson Cancer CenterP3BB (65)
METHOTREXATE
Acute Biphenotypic Leukemia
Fred Hutchinson Cancer CenterP3BB (65)
Pembrolizumab
Renal Pelvis Urothelial Carcinoma
Fred Hutchinson Cancer CenterP3BB (65)
Pembrolizumab
Ureter Transitional Cell Carcinoma
Fred Hutchinson Cancer CenterP3BB (65)
Pembrolizumab
Bladder Transitional Cell Carcinoma
Fred Hutchinson Cancer CenterP3BB (65)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4)
Bladder Transitional Cell Carcinoma
Fred Hutchinson Cancer CenterP2BB (65)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4)
Ureter Transitional Cell Carcinoma
Fred Hutchinson Cancer CenterP2BB (65)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4)
Stage IV Bladder Cancer AJCC v8
Fred Hutchinson Cancer CenterP2BB (65)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4)
Malignant Renal Pelvis Neoplasm
Fred Hutchinson Cancer CenterP2BB (65)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4)
Ureter Cancer
Fred Hutchinson Cancer CenterP2BB (65)
Fludarabine
CD4+/CD56+ Hematodermic Neoplasm
Fred Hutchinson Cancer CenterP2BB (65)
Fludarabine
Mast Cell Leukemia
Fred Hutchinson Cancer CenterP2BB (65)
Jcar017 (Lisocabtagene Maraleucel)
Primary Mediastinal Large B-Cell Lymphoma
Fred Hutchinson Cancer CenterP2BB (65)
TACROLIMUS
Hematopoietic And Lymphoid Cell Neoplasm
Fred Hutchinson Cancer CenterP2BB (65)
Fludarabine
Plasma Cell Myeloma
Fred Hutchinson Cancer CenterP4BB (64)
Cediranib
Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Fred Hutchinson Cancer CenterP3BB (64)
CYCLOSPORIN A
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Fred Hutchinson Cancer CenterP3BB (64)
Decitabine
Chronic Myelomonocytic Leukemia
Fred Hutchinson Cancer CenterP3BB (64)
Nivolumab
Nonpapillary Renal Cell Carcinoma
Fred Hutchinson Cancer CenterP3BB (64)
Nivolumab
Metastatic Cancer
Fred Hutchinson Cancer CenterP3BB (64)
Showing 101 to 125 of 567 assets
PreviousPage 5 of 23Next